Unknown PHASE3 INTERVENTIONAL 4-arm NCT04360122

Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19

Impact of Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19

Sponsor: Ain Shams University

Conditions Coronavirus Disease (COVID-19)

Interventions Isoprinosine Levamisole Levamisole and Isoprinosine

Updated 6 times since 2020 Last updated: May 3, 2020 Started: May 20, 2020 Primary completion: Nov 1, 2020 Completion: Dec 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Coronavirus Disease (COVID-19) and is currently ongoing. Ain Shams University leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jun 2022 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jun 2022 [monthly]

Not Yet Recruiting PHASE3
Jun 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE3

▶ Show 1 earlier version

May 2020 — Jun 2020 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt